Galera Therapeutics, Inc. (GRTX) DCF Valuation

Galera Therapeutics, Inc. (GRTX) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Galera Therapeutics, Inc. (GRTX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Galera Therapeutics, Inc. (GRTX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Galera Therapeutics, Inc. (GRTX) valuation with this customizable DCF Calculator! Featuring real Galera Therapeutics, Inc. (GRTX) financials and adjustable forecast inputs, you can test scenarios and uncover Galera Therapeutics, Inc. (GRTX) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -50.7 -69.0 -72.6 -50.6 -46.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .4 .8 .1 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -51.0 -69.4 -73.3 -50.7 -47.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 112.3 72.8 71.2 31.6 18.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 3.9 5.1 5.0 3.6 1.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.6 -.5 -.3 .0 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -50.9 -69.4 -79.9 -50.7 -47.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -47.4 -68.3 -79.5 -52.0 -49.0 -1.4 .0 .0 .0 .0
WACC, % 9.05 9.05 9.05 9.05 9.05 9.05 9.05 9.05 9.05 9.05
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -17
Equity Value 16
Diluted Shares Outstanding, MM 45
Equity Value Per Share 0.35

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real GRTX financials.
  • Actual Data Insights: Historical performance data and forward-looking projections (highlighted in the yellow cells).
  • Assumption Flexibility: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Galera Therapeutics' valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for clarity and simplicity, complete with step-by-step guidance.

Key Features

  • Customizable Clinical Parameters: Adjust vital inputs such as trial success rates, market penetration, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
  • High-Precision Accuracy: Incorporates Galera Therapeutics' actual financial data for dependable valuation results.
  • Simplified Scenario Analysis: Easily evaluate various assumptions and analyze results side-by-side.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Galera Therapeutics, Inc. (GRTX) preloaded data.
  • 2. Modify Assumptions: Adjust key variables such as growth rates, WACC, and capital expenditures.
  • 3. Review Results Instantly: The DCF model automatically calculates intrinsic value and NPV.
  • 4. Explore Scenarios: Analyze multiple forecasts to evaluate different valuation results.
  • 5. Present with Confidence: Deliver professional valuation insights to bolster your decision-making process.

Why Choose Galera Therapeutics, Inc. (GRTX) Calculator?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for Galera Therapeutics.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
  • Detailed Insights: Automatically computes Galera’s intrinsic value and Net Present Value for informed decision-making.
  • Preloaded Data: Includes historical and projected data for precise analysis and starting points.
  • Professional Quality: Perfect for financial analysts, investors, and healthcare business consultants focusing on biotech.

Who Should Use Galera Therapeutics, Inc. (GRTX)?

  • Investors: Gain insights into innovative therapies and make informed investment choices.
  • Healthcare Analysts: Streamline your research with comprehensive data on clinical developments.
  • Consultants: Tailor presentations or reports with up-to-date information on Galera's pipeline.
  • Biotech Enthusiasts: Enhance your knowledge of cutting-edge treatments and their market potential.
  • Educators and Students: Utilize it as a resource for studies in biotechnology and pharmaceutical sciences.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Galera Therapeutics, Inc. (GRTX).
  • Real-World Data: Galera Therapeutics’ historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company’s performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Galera Therapeutics, Inc. (GRTX).
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results related to Galera Therapeutics, Inc. (GRTX).

No products were found matching.